CBIO eps in a glimpse
Analyst Rating Consensus
10
Ratings
CBIO Price Target
Highest Price Target
$75.00
NaN% Upside
)Mean Price Target
$24.55
NaN% Upside
)Lowest Price Target
$3.50
566.41% Upside
)CBIO Recent Analyst Ratings
Actual EPS vs Estimated EPS
How EPS can be helpful
Understanding the true essence of Earnings Per Share (EPS) for a company can be a complex endeavor. EPS, essentially a measure of a company's profitability on a per-share basis, is often used by investors as a barometer of financial health. However, it's crucial to recognize that EPS can be subject to manipulation through various accounting techniques and management strategies.
CBIO Earnings History
Frequently Asked Questions
Brokerage firms have given CBIO stock an average recommendation of Buy. 10 analysts have given their ratings to CBIO out of which 4 analysts have given strong buy call, 6 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $24.55 gives the stock implied upside of roughly 4,574.41% over the next year or so.
Analysts suggest CBIO's stock price would rise to a high of $75.00.
Within the next 12 months, analysts predict the CBIO stock price could move to $3.50.
CBIO stock has an average analyst estimate of $24.55.
CBIO shares are currently trading 4,574.41% above this price target.
Its quarterly earnings per share (EPS) came in at -$0.04 versus consensus estimates of -$0.05, and above the comparable year-ago quarter’s EPS of -$0.16.
CBIO's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
The analysts have projected N/A EPS growth for CBIO in the next five years, compared to growth rates of 48.84% in the past five years.